145 related articles for article (PubMed ID: 25929156)
1. Impact of the 2009 AJCC staging guidelines for melanoma on the number of mitotic figures reported by dermatopathologists at one institution.
Larson AR; Rothschild B; Walls AC; Granter SR; Qureshi AA; Murphy GF; Laga AC
J Cutan Pathol; 2015 Aug; 42(8):536-41. PubMed ID: 25929156
[TBL] [Abstract][Full Text] [Related]
2. Morphologic Forms and Classification of Dermal Mitotic Figure Density in Primary Cutaneous Melanoma: A Retrospective Study.
Marsch AF; McKee RM; Hinds BR
Am J Dermatopathol; 2020 Jan; 42(1):35-40. PubMed ID: 31884499
[TBL] [Abstract][Full Text] [Related]
3. Influence of variability in assessment of Breslow thickness, mitotic rate and ulceration among US pathologists interpreting invasive melanoma, for the purpose of AJCC staging.
Taylor L; Hood K; Reisch L; Elmore J; Piepkorn M; Barnhill R; Knezevich S; Radick A; Elder D
J Cutan Pathol; 2018 Aug; 45(8):588-596. PubMed ID: 29717800
[TBL] [Abstract][Full Text] [Related]
4. Assessment of mitotic rate reporting in melanoma.
Burton AL; Egger ME; Gilbert JE; Stromberg AJ; Hagendoorn L; Martin RC; Scoggins CR; McMasters KM; Callender GG
Am J Surg; 2012 Dec; 204(6):969-74; discussion 974-5. PubMed ID: 23036603
[TBL] [Abstract][Full Text] [Related]
5. Global and mitosis-specific interobserver variation in mitotic count scoring and implications for malignant melanoma staging.
Saldanha G; Ali R; Bakshi A; Basiouni A; Bishop R; Colloby P; Craig P; Da Forno P; Edward S; Espinosa de Los Monteros O; Evans A; Jamieson L; Rytina E; Bamford M
Histopathology; 2020 May; 76(6):803-813. PubMed ID: 31879972
[TBL] [Abstract][Full Text] [Related]
6. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
Sekula-Gibbs SA; Shearer MA
Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
[TBL] [Abstract][Full Text] [Related]
7. How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.
Caldarella A; Fancelli L; Manneschi G; Chiarugi A; Nardini P; Crocetti E
J Cancer Res Clin Oncol; 2016 Jan; 142(1):73-6. PubMed ID: 26113451
[TBL] [Abstract][Full Text] [Related]
8. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of AJCC staging parameters in primary cutaneous melanoma: an analysis of 4,924 cases.
Niebling MG; Haydu LE; Karim RZ; Thompson JF; Scolyer RA
Ann Surg Oncol; 2013 Nov; 20(12):3969-75. PubMed ID: 23851608
[TBL] [Abstract][Full Text] [Related]
10. A probabilistic analysis of mitotic counts in melanoma.
Vollmer RT
Am J Clin Pathol; 2014 Feb; 141(2):213-8. PubMed ID: 24436268
[TBL] [Abstract][Full Text] [Related]
11. Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients.
Ponti G; Pollio A; Cesinaro AM; Pellacani G; Magnoni C; Seidenari S
Cancer Epidemiol; 2012 Jun; 36(3):303-5. PubMed ID: 22153914
[TBL] [Abstract][Full Text] [Related]
12. Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma.
Casper DJ; Ross KI; Messina JL; Sondak VK; Bodden CN; McCardle TW; Glass LF
Am J Dermatopathol; 2010 Oct; 32(7):650-4. PubMed ID: 20559123
[TBL] [Abstract][Full Text] [Related]
13. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma.
Busam KJ
Am J Clin Pathol; 2001 May; 115(5):743-6. PubMed ID: 11345839
[TBL] [Abstract][Full Text] [Related]
14. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.
Chu VH; Tetzlaff MT; Torres-Cabala CA; Prieto VG; Bassett R; Gershenwald JE; McLemore MS; Ivan D; Wang WL; Ross MI; Curry JL
Biomed Res Int; 2013; 2013():898719. PubMed ID: 24369020
[TBL] [Abstract][Full Text] [Related]
15. Mitotic rate in cutaneous melanomas ≤1 mm in thickness: a prospective study.
Litzner BR; Etufugh CN; Stepenaskie S; Hynan LS; Cockerell CJ
Am J Dermatopathol; 2012 Dec; 34(8):827-32. PubMed ID: 22878366
[TBL] [Abstract][Full Text] [Related]
16. AJCC melanoma staging update: impact on dermatopathology practice and patient management.
Piris A; Mihm MC; Duncan LM
J Cutan Pathol; 2011 May; 38(5):394-400. PubMed ID: 21385199
[TBL] [Abstract][Full Text] [Related]
17. Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practice.
Garbe C; Eigentler TK; Bauer J; Blödorn-Schlicht N; Fend F; Hantschke M; Kurschat P; Kutzner H; Metze D; Pressler H; Reusch M; Röcken M; Stadler R; Tronnier M; Yazdi A; Metzler G
J Dtsch Dermatol Ges; 2011 Sep; 9(9):690-9. PubMed ID: 21651721
[TBL] [Abstract][Full Text] [Related]
18. Final version of 2009 AJCC melanoma staging and classification.
Balch CM; Gershenwald JE; Soong SJ; Thompson JF; Atkins MB; Byrd DR; Buzaid AC; Cochran AJ; Coit DG; Ding S; Eggermont AM; Flaherty KT; Gimotty PA; Kirkwood JM; McMasters KM; Mihm MC; Morton DL; Ross MI; Sober AJ; Sondak VK
J Clin Oncol; 2009 Dec; 27(36):6199-206. PubMed ID: 19917835
[TBL] [Abstract][Full Text] [Related]
19. 2010 TNM staging system for cutaneous melanoma...and beyond.
Gershenwald JE; Soong SJ; Balch CM;
Ann Surg Oncol; 2010 Jun; 17(6):1475-7. PubMed ID: 20300965
[No Abstract] [Full Text] [Related]
20. [Primary cutaneous melanoma: prognostic factors not included in the classification of the American Joint Committee on Cancer].
Tejera-Vaquerizo A; Solís-García E; Ríos-Martín JJ; Moreno-Ramírez D
Actas Dermosifiliogr; 2011 May; 102(4):255-63. PubMed ID: 21440241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
